Cargando…

Investigating potential drivers of increased central-line–associated bloodstream infections during the SARS-CoV-2 omicron-variant surge

Background: Central-line–associated bloodstream infection (CLABSI) rates increased nationally during COVID-19, the drivers of which are still being characterized in the literature. CLABSI rates doubled during the SARS-CoV-2 omicron-variant surge at our rural academic medical center. We sought to ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, HeeEun, Stewart, Kathleen O., Khan, Asif, Casale, Stephanie C., Barker, Caitlin Adams, Kim, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Clabsi
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594315/ http://dx.doi.org/10.1017/ash.2023.284

Ejemplares similares

Investigating potential drivers of increased central line–associated bloodstream infections during the coronavirus disease 2019 (COVID-19) Omicron surge
por: Kang, HeeEun, et al.
Publicado: (2023)

Identifying risk factors for pediatric central-line–associated bloodstream infections
por: Conrad, Paula, et al.
Publicado: (2023)

Effectiveness of a Multidisciplinary Team-Approach on Central-Line–Associated Bloodstream Infections
por: Suleyman, Geehan, et al.
Publicado: (2021)

Central-line associated bloodstream infection (CLABSI) in patients hospitalized with COVID-19
por: Kang, Minji, et al.
Publicado: (2022)

The evaluation of central-line–associated bloodstream infection (CLABSI) preventability at an academic institution
por: Hsueh, Leon, et al.
Publicado: (2022)

Central-line associated bloodstream infections secondary to strict anaerobes: Time for A definition change?
por: Seidelman, Jessica, et al.
Publicado: (2022)

Evaluating racial disparities in central-line–associated bloodstream infections for Tennessee hospitals, 2018–2021
por: Godwin, Simone, et al.
Publicado: (2023)

Epidemiology of central-line–associated bloodstream infection mortality in Canadian NICUs before and after 2017
por: Spagnuolo, Maria, et al.
Publicado: (2023)

Bloodstream infection burden among cancer clinic patients with PICC Lines: A prospective, observational study
por: Bethlahmy, Jessica, et al.
Publicado: (2023)

The effectiveness of a dedicated central venous access care team to prevent catheter-related bloodstream infections
por: Charles Fil de Lara, Fortune, et al.
Publicado: (2022)

Examining CLABSI rates by central-line type
por: DiBiase, Lauren, et al.
Publicado: (2023)

End-of-life care and hospital-acquired bloodstream infection
por: Zarnoski, Melanie, et al.
Publicado: (2023)

Hospital-acquired bloodstream infections in patients with and without hepatic failure
por: Bosco, Jordan, et al.
Publicado: (2022)

Human factors analysis of the disinfection of central-line needleless connectors
por: Martinello, Richard, et al.
Publicado: (2022)

Peripheral intravascular catheter-associated bloodstream infection in the medical–surgical ICU
por: Hogle, Nancy, et al.
Publicado: (2022)

Relative risk of primary bloodstream infection in patients with mechanical circulatory support devices
por: Wolansky, Rachel, et al.
Publicado: (2023)

Catheter-related bloodstream infections in patients receiving hemodialysis in a single Philippine tertiary-care center
por: Mantaring, Dan Meynard, et al.
Publicado: (2023)

Blood-culture ordering practices in patients with a central line at an academic medical center–Iowa, 2020
por: Kovoor, Elias, et al.
Publicado: (2022)

Novel strategies to reduce central-line–associated blood stream infection (CLABSI) events in the neonatal intensive care unit
por: Camelo, Ingrid, et al.
Publicado: (2023)

Inequities in CLABSI Rates in a Children’s Hospital by Race, Ethnicity, and Language Preference
por: McGrath, Caitlin, et al.
Publicado: (2021)

Sustainable Neonatal CLABSI Surveillance: Consensus Toward New Criteria in the Netherlands
por: Heijting, Ilja, et al.
Publicado: (2021)

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy complications
por: Kaul, Christina, et al.
Publicado: (2022)

Estimating racial differences in risk for CLABSI in a large urban healthcare system
por: Licitra, Giancarlo, et al.
Publicado: (2023)

Retrospective data analysis of CLABSI rates at Baystate Medical Center during the COVID-19 pandemic
por: Satta, Giovanni, et al.
Publicado: (2023)

2179. Variability in the Application of Surveillance Definitions for Central Line-Associated Bloodstream Infection Across U.S. Hospitals
por: Barker, Caitlin Adams, et al.
Publicado: (2018)

Croup during the Coronavirus Disease 2019 Omicron Variant Surge
por: Tunҫ, Emine M., et al.
Publicado: (2022)

COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge
por: Bronstein, Yotam, et al.
Publicado: (2022)

Mass COVID-19 testing and its implications amidst the Omicron variant surge
por: Tan, Li Feng, et al.
Publicado: (2022)

Inpatient psychiatry response to the SARS-CoV-2 Omicron variant surge
por: Russ, Mark J., et al.
Publicado: (2022)

The Outcomes of Covid-19 in Patients with CLL during the Omicron Sub-Variants Surge
por: Bronstein, Yotam, et al.
Publicado: (2022)

Echocardiographic Findings in Patients With COVID-19 With Myocardial Injury During the Omicron Variant Surge
por: Alam, Loba, et al.
Publicado: (2022)

Right Ventricular Abnormality in Patients Hospitalized With COVID-19 Infection During Omicron Variant Surge
por: Salem Omar, Alaa Mabrouk, et al.
Publicado: (2022)

Central line-associated bloodstream infections in neonates
por: Cho, Hye Jung, et al.
Publicado: (2019)

Treatment of central line-associated bloodstream infections
por: Guenezan, Jérémy, et al.
Publicado: (2018)

The impact of central line insertion bundle on central line-associated bloodstream infection
por: Tang, Hung-Jen, et al.
Publicado: (2014)

Effect of Central Line Bundle Compliance on Central Line-Associated Bloodstream Infections
por: Lee, Kyoung Hwa, et al.
Publicado: (2018)

COVID-19 testing demand amidst Omicron variant surge: Mass hysteria or population health need?
por: Bhagavathula, Akshaya Srikanth, et al.
Publicado: (2022)

Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge
por: Abdelrahim, Maen, et al.
Publicado: (2022)

A Small Surge in Incidence of SARS-CoV-2 Omicron Variant in the “Dynamic Zero” Period
por: Li, Xiaona, et al.
Publicado: (2023)

Impact of Omicron surge in community setting in greater Paris area
por: Dinh, Aurélien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ev1fdlugrgccciqamnpgdrp5c5